Abstract
Natural products have provided valuable leads for drug design and development, and it is recognized that bacteria from Streptomycetaceae and Pseudonocardiaceae families are among the most prolific producers of natural products that have been developed into drugs. However, pharmaceutical companies have deemphasized their natural products discovery programs in the last decades. At the same …